These findings provide novel insights into the molecular mechanisms underlying spinal deformity progression in AIS, linking PTPμ depletion to aberrant OPN-α5β1 integrin signaling and highlighting potential therapeutic targets to stop, mitigate, or prevent scoliosis. This evidence concerns the gene SPP1 and androgen insensitivity syndrome.